Abstract Little is known about the regulatory mechanisms of endothelial cell (EC) proliferation by retinal pericytes and vice versa. In a model of coculture with bovine retinal pericytes lasting for 24 h, rat brain ECs showed an increase in arachidonic acid (AA) release, whereas Western blot and RT-PCR analyses revealed that ECs activated the protein expression of cytosolic phospholipase A 2 (cPLA 2 ) and its phosphorylated form and calcium-independent intracellular phospholipase A 2 (iPLA 2 ). No activation of the same enzymes was seen in companion pericytes. In ECs, the protein level of phosphorylated extracellular signal-regulated kinase (ERK) 1/2 was also enhanced significantly, a finding not observed in cocultured pericytes. The expression of protein kinase C-a (PKCa) and its phosphorylated form was also enhanced in ECs. Wortmannin, LY294002, and PD98059, used as inhibitors of upstream kinases (the PI3-kinase/Akt/PDK1 or MEK-1 pathway) in cultures, markedly attenuated AA release and the expression of phosphorylated forms of endothelial cPLA 2 , PKCa, and ERK1/2. By confocal microscopy, activation of PKCa in perinuclear regions of ECs grown in coculture as well as strong activation of cPLA 2 in ECs taken from a model of mixed culture were clearly observed. However, no increased expression of both enzymes was found in cocultured pericytes. Our findings indicate that a sequential activation of PKCa contributes to endothelial ERK1/2 and cPLA 2 phosphorylation induced by either soluble factors or direct cell-tocell contact, and that the PKCa-cPLA 2 pathway appears to play a key role in the early phase of EC-pericyte interactions regulating blood retina or blood-brain barrier maturation.-
The structural basis of the blood-brain barrier (BBB) is not only a specialized brain capillary endothelial cell (EC) but encompasses a highly organized complex consisting of an endothelium, pericytes, and astrocytic foot processes. For the endothelium to form a selective barrier between the blood stream and tissues, vascular maturation requires the formation of tight EC-to-cell contacts, the downregulation of endothelial proliferation, the deposition of a basal lamina to which the endothelium tightly adheres, and the recruitment of supporting cells to the vessel walls such as pericytes or smooth muscle cells (1) (2) (3) .
Pericytes have received much less attention than the other components of microvascular beds. These contractile cells of mesenchymal lineage have long processes paralleling the capillary axis and short processes encircling the capillary. The current view of the role of pericytes in early stages of angiogenesis states that the initial endothelial tubes form without pericyte contact and that subsequent acquisition of pericyte coverage leads to vessel remodeling and maturation (4) . This view has been challenged because it was shown that pericytes invest in actively sprouting and remodeling vessels (4, 5) . Retinal pericytes have a mitogenic effect on retinal microvascular ECs (6) , which may have important implications in new vessel formation. In an in vitro model of BBB established by coculturing immortalized ECs with brain pericytes that expressed tumor growth factor (TGF)-b1, the permeability of ECs was decreased significantly (7) . Furthermore, in mixed cultures, pericytes have an antiproliferative effect on ECs (8) (9) (10) . However, the molecular basis of the induction signal is not yet clear, whether soluble factors (pericytederived angiopoietin-1 or TGF-b) or cell-to-cell contact.
Neovascularization and the vascular maturation process are under the control of phosphorylated p44/p42 mitogen-activated protein kinase (MAPK) and phosphorylated protein kinase C (PKC) isoforms upstream of p44/ p42 MAPK and represent the main signaling cascades that become activated in angiogenic ECs (11) . The two main sources of angiogenic signals (i.e., growth factors and the extracellular matrix) are transduced through the extracellular signal-regulated kinase (ERK) PI3K/Akt/ERK signaling system. Cytosolic phospholipase A 2 (cPLA 2 ), which regulates the provision of arachidonic acid (AA), cyclooxygenase-2, and prostaglandin E 2 release, is highly upregulated in angiogenic ECs during tumor progression (12) , promoting integrin aVb3-mediated EC adhesion, spreading, and angiogenesis through prostaglandin-cAMP-PKAdependent activation of the small GTPase Rac (13) .
To study these subjects, several in vitro models of cocultures have been used. For instance, astroglial cells were cultivated with brain ECs to produce a coculture model to study the permeability of cell layers (14) . In the retina, macroglia (astrocytes and Mü ller cells) can enhance the barrier properties of retinal blood vessels by the production of factors that contribute to tight junction formation. Although mutual structural and functional interaction between astrocytes and ECs has been documented, less is known about the interaction between pericytes and ECs in mature microvessels. The potent vasoconstrictor endothelin-1 is a putative endothelium-pericyte signal regulating multicellular functional units of microvessels by a mechanism partially sensitive to PKC activation (15) . Thus, although we are beginning to understand that pericytes are important in a number of situations in vessel formation, maintenance, and dysfunction (retinal diseases), we lack knowledge about how and what they signal to the endothelium.
The aim of this study was to scrutinize the reaction conditions that enable retinal pericytes to maintain the differentiated BBB phenotype in quiescent EC cultures or to induce EC maturation during the angiogenic state (angiogenic sprouting). This last phase may activate the expression of several specific proteins less expressed under quiescent conditions (no vessel formation). Incidentally, these proteins may represent potential targets for antiangiogenesis therapy in ocular diseases as well as cancer. We hypothesized that the activation of the PKC-ERK1/ 2-cPLA 2 pathway may be involved in several endothelial functions, including BBB promotion, as well as angiogenesis. A role for PKC and PLA 2 to mediate cell-to-cell interactions is suggested, as several agonists, including endothelin-1, which increased prostacyclin production, increased at the same time PKC, MAPK, and PLA 2 activities in both isolated ECs (16) and pericytes (15) . In addition, monocyte adhesion to human umbilical vein endothelial cells activated monocytic PKCa, PKCy, and both calciumindependent intracellular phospholipase A 2 (iPLA 2 ) and cPLA 2 activities (17). PLA 2 s are a diverse group of enzymes that catalyze the hydrolysis of the sn-2 substituent from glycerophospholipid substrates to yield a free fatty acid and 2-lysophospholipid acceptors (18) . Among the PLA 2 s is an 85 kDa cPLA 2 that requires Ca 21 for catalysis and a calcium-independent PLA 2 , iPLA 2 b, for which several potential functions have been proposed, including a housekeeping role in phospholipid remodeling and a signaling role in cell growth, apoptosis, secretion, inflammation, and oxidant-induced cell injury (19) (20) (21) . A number of observations that iPLA 2 has a functional role in cellular signaling in addition to its roles in AA release and phospholipid remodeling have been reported (22) . iPLA 2 mediates the phosphorylation of transcription factors through a PKAdependent pathway (23) .
Activation of cPLA 2 is associated with a redistribution of the enzyme within the cell (24) (25) (26) . The hydrolysis of glycerophospholipids to liberate fatty acids is in fact regulated by cPLA 2 translocation to membranes and by MAPK-catalyzed phosphorylation (19, 25, 27) . There are several reports indicating that cPLA 2 may be a substrate for PKC phosphorylating activity (17, 28) . Our recent work has also provided in vitro evidence that PKC upstream activates cPLA 2 after stimulation of ECs by oxidized LDL or of pericytes by b-amyloid peptides (29, 30) . To date, direct evidence for any of the PKC isoforms being involved in the signaling pathway during endothelial cell-pericyte coupling has not been defined. Therefore, in cocultures of immortalized rat brain GP8.39 ECs and retinal pericytes (an in vitro model of BBB), we investigated the induction of PLA 2 s in both cell types and illustrated the role of some PKCs and MAPKs, comparing the data obtained with those of their respective monocultures. We were able to show that in a coculture system, with or without a direct cell-to-cell contact, endothelial PKCa/y and cPLA 2 protein expression were activated compared with those that evaluated in ECs grown alone.
EXPERIMENTAL PROCEDURES

Materials
Reagent-grade chemicals were purchased from Sigma Chemical Co. (St. Louis, MO) or E. Merck (Darmstadt, Germany). Collagenase-dispase, fatty acid-free BSA, and the kinase inhibitors wortmannin, LY294002, PD98059, bromoenol lactone (BEL), and arachidonoyl trifluoromethyl ketone (AACOCF 3 ) were purchased from Calbiochem (La Jolla, CA). Primary antibodies against cPLA 2 (mouse monoclonal), PKCa (mouse monoclonal), rabbit polyclonal antibody against ERK1 or ERK2, mouse monoclonal antibody to phospho-ERK1/2, goat polyclonal anti-phospho-PKCa, mouse monoclonal antibody against actin, and rabbit polyclonal von Willebrandt factor (vWF) antibody were purchased from Santa Cruz Biotechnology, Inc. iPLA 2 (rabbit polyclonal) antibody was from Cayman Chemical Co. Rabbit monoclonal antiphospho-cPLA 2 was obtained from Cell Signaling Technology, Inc. (Beverly, MA). All other chemicals were reagent grade.
Cell cultures
Immortalized rat brain ECs (GP8.39) were generously provided by Dr. John Greenwood (Department of Clinical Ophthal-mology, University College, London) (31) and fed with F10 Ham's medium supplemented with 10% fetal bovine serum, 80 mg/ml heparin, 2 mM glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin. The cell line was already characterized, and our cell cultures were prepared and characterized according to previously described procedures (31, 32) . Morphological changes and cell viability determined by [3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl-tetrazolium bromide] test were assessed as reported previously (29, 33) . Pure microvessel pericyte cultures were prepared from bovine retinas as described previously (34) . The isolated cells were then cultured in DMEM supplemented with 2 mM glutamine, 10% fetal bovine serum, 100 U/ml penicillin, and 100 mg/ml streptomycin.
Cocultures without direct cell-to-cell contact Culture plates and inserts (Transwells; Corning, Inc., Corning, NY) were coated on the upper side with 150 ml of a 2 mg/ml solution of rat tail collagen containing 10-fold concentrated DMEM plus 0.3 M NaOH. The coating was dried for 1 h at 37jC and rinsed twice with water and once with Ca 21 -and Mg 21 -free PBS before being placed in complete medium. Before performing cocultures, ECs or pericytes were placed (40,000 cells/cm 2 ) and seeded onto six-well plates treated with collagen or skin porcine gelatin, respectively. At the same time, the two cell types were plated on the Transwell inserts (40,000 cells/cm 2 ) with the same substrate coverages. At confluence, ECs or pericytes on inserts were placed onto the plates containing, respectively, pericytes or ECs on the bottom (culture medium; 1 ml within the insert and 2 ml in the outer well; pericyte-to-EC ratio, 1:1). After a coincubation for 24 h in EC/pericyte medium (50% DMEM plus F10 Ham's, each containing 10% FBS), inserts containing conditioning cells were discarded, whereas cells on the plate were washed three times with ice-cold PBS and scraped with a rubber policeman. Lysates were performed as described (29, 33) . EC or pericyte (40,000 cells/cm 2 ) monocultures were established in parallel as controls.
Cocultures with direct cell-to-cell contact
To make an in vitro model of the BBB based on direct contact of cells, pericytes were first plated on the outside of the polycarbonate membrane (40,000 cells/cm 2 ) of the Transwell inserts (six-well type, 0.4 mm pore size) and directed upside down in the well culture plate. After pericytes had adhered, the Transwells were inverted and reinserted onto six-well plates, and ECs were plated on the top surface of the insert (40,000 cells/cm 2 ). After coincubation for 24 h, cells grown on both sides of the inserts were scraped with a rubber policeman and saved separately.
AA release
Cultures of ECs or pericytes were established on six-well plates and incubated with 0.3 mCi/dish [1- 14 C]AA (Dupont NEN) in F10 Ham's (ECs) or DMEM (pericytes) medium containing 2 mM glutamine and 5% fetal calf serum for 24 h at 37jC. The cells were washed three times, 5 min per wash, with HBSS buffer and coincubated without direct cell-to-cell contact with pericytes or ECs in serum-free DMEM (50%)-F10 Ham's (50%) medium containing 0.5% BSA as a trap for released AA in the absence or presence of 5 mM EDTA or in the presence of inhibitors such as wortmannin (60 nM) plus LY294002 (20 mM), PD98059 (25 mM), AACOCF 3 (50 mM), or BEL (25 mM) dissolved in DMSO stock solution for 24 h. The effects of PI3-kinase or MEK1 inhibitors (24 h exposure) and AACOCF 3 or BEL or EDTA on AA release were also tested in the prelabeled cells (control cultures in solo). After incubation, the medium was removed and centrifuged for 5 min. The supernatant fraction was concentrated by lyophilization to 1 ml, and an aliquot (100 ml) was taken to determine the radioactivity in total medium by liquid scintillation spectroscopy, normalizing to protein. Then, it was acidified with 1 M HCl to bring the pH to 3.0 (medium turns yellow) and frozen for subsequent analysis. Acidified medium was extracted three times in equal volumes of ethyl acetate (33) . The organic layer was evaporated under nitrogen, and the residue was dissolved in ethanol. In some analyses, AA and eicosanoid derivatives were separated on silica gel 60 TLC plates developed with the organic phase of ethyl acetate-isooctane-acetic acid-water mixture (11:5:2:10, v/v). The lipid zones were located with I 2 vapor or by preparing autoradiographs (Berthold DAR-signal analyzer) and scraped into scintillation vials, and the radioactivity was measured by liquid scintillation spectroscopy. Identification of AA (main spot) and lipids (minor bands) was based on a comparison of their TLC mobilities with those of authentic unlabeled standards.
Preparation of cells for fluorescence confocal microscopy
To detect the expression and translocation of the PKCa isoform as well as cPLA 2 , confocal microscopy was performed on ECs or pericytes cultured on microscope cover glasses placed on a six-well plate for noncontact cocultures as described above. Mixed cultures of ECs and pericytes (1:1) were also performed; glass coverslips were placed onto six-well plates before gelatin coating. ECs and pericytes were mixed and plated in 2 ml of 50% EC/50% pericyte medium.
After 24 h of coincubation, cells were fixed by adding 4% paraformaldehyde in PBS and processed for immunocytochemistry as described previously (29) using either anti-PKCa or anti-cPLA 2 antibodies. Distribution of PKCa and cPLA 2 immunocomplexes was observed by confocal immunofluorescence microscopy using a Leica TCS NT confocal laser scanning microscope. Single lower power scans were followed by 16-22 serial optical sections of randomly chosen cells in four to five fields per coverslip. The average fluorescence (mean 6 SD) intensity (pixels) in individual cell bodies was measured throughout the stack. Each condition was tested on a total of 60-80 cells, resulted from at least three coverslips obtained from at least two different cultures.
Western blotting
After 24 h of coincubation, ECs and pericytes were lysed as described previously (29) . The protein content of the cell lysate was quantified by Lowry's assay, and immunoblots were assessed as described elsewhere (29) . Membranes were incubated with primary antibodies against cPLA 2 (mouse monoclonal; 1:500 dilution), iPLA 2 (rabbit polyclonal; 1:1,000 dilution), PKCa (mouse monoclonal; 1:2,000 dilution), or phospho-ERK (mouse monoclonal; 1:250 dilution). The membranes were then incubated with secondary antibodies for 1 h at room temperature, and the immunocomplexes were detected by enhanced chemiluminescence reagent (ECL; Amersham).
Total RNA isolation and RT-PCR
Total cellular RNA was purified from confluent and quiescent GP8.39 cells and pericytes using TRIzol reagent (Invitrogen Life Technologies) according to the manufacturer's instructions and redissolved in 30 ml of RNase-free water. RNA concentrations and purity were estimated by optical density at 260 and 280 nm. Firststrand cDNA was reverse-transcribed in a 20 ml reaction volume with 200 units of SuperScript II, 50 ng of random examers, 125 mM deoxynucleoside triphosphate, 10 mM dithiothreitol, 50 mM Tris-HCl, pH 8.3, 75 mM KCl, and 3 mM MgCl 2 (Invitrogen Life Technologies). The reaction, carried out at 42jC for 50 min, was stopped at 70jC for 10 min. PCR was performed in 10 ml final volumes containing 1 ml of cDNA, 8 pmol of each primer, 1.7 mM deoxynucleoside triphosphate mix, and 1 unit of TaqMan Gold DNA polymerase (Applied Biosystems) in 13 buffer II. Cycling parameters were as follows: initial denaturing, 95jC for 10 min; denaturing, 95jC for 35 s; annealing at specific temperature (55-60jC) for 35 s; extension, 72jC for 45 s; and a final extension step at 72jC for 5 min. The appropriate number of PCR cycles was established as described below. Specific primers for rat cPLA 2 , iPLA 2 , and GAPDH genes (synthesized by Invitrogen Life Technologies) were used in semiquantitative RT-PCR on GP8.39. A 450 bp product, using a forward primer (5 ¶-AAGGCCAAGTGA-CACCAGCC-3 ¶) and a reverse primer (5 ¶-GAAACAGAGCAACGA-GATGGG-3 ¶), was amplified for rat cPLA 2 . A 353 bp product, using a forward primer (5 ¶-AAGTGAACGTGTTCGAGAGG-3 ¶) and a reverse primer (5 ¶-GATGATGCGGCTGTGATGG-3 ¶), was amplified for iPLA 2 . The primers used for GAPDH were 5 ¶-TAGACAAGATGGTGAAGG-3 ¶ (forward) and 5 ¶-GCAGGGATGA-TGTTCTGG-3 ¶ (reverse), and their amplification product was 650 bp. Specific primers for bovine cPLA 2 , iPLA 2 , and b-actin genes (synthesized by Invitrogen Life Technologies) were used in semiquantitative RT-PCR assays on pericytes. A 293 bp product, using a forward primer (5 ¶-ATTGCCCGACTATCATTCAC-3 ¶) and a reverse primer (5 ¶-ATGCTGTGGGTTTGCTTAG-3 ¶), was amplified for cPLA 2 . A 343 bp product, using a forward primer (5 ¶-ATCACAGCCACATCATCAGC-3 ¶) and a reverse primer (5 ¶-CCATGATGTTGCAGCGAGC-3 ¶), was amplified for iPLA 2 . For bactin, the primers used were 5 ¶-CCCGTGCTGCTGACCGAG-3 ¶ (forward) and 5 ¶-ACCGTGTTGGCGTAGAGG-3 ¶ (reverse), and their amplification product was 590 bp.
GAPDH and b-actin genes were used as internal control templates to normalize relative changes of target mRNA in RT-PCR on GP8.39 and pericytes, respectively. For each target gene to be analyzed and for each separate experiment, the exponential phase of amplification was determined such that product formation was related to starting template. Preliminarily, PCR was performed at various cycles, with positive and negative controls, to determine the cycle at which products became visible within the exponential phase of amplification. The conditions were chosen so that none of the RNA analyzed reached a plateau at the end of the amplification protocol (i.e., they were in the exponential phase of amplification). Thirty-two, 32, and 34 cycles of amplification for cPLA 2 , iPLA 2 , and GAPDH, respectively, were chosen to yield the linear increase of PCR products before reaching plateaus in GP8.39. The same conditions were also ensured by 31, 32, and 30 cycles of amplification for cPLA 2 , iPLA 2 , and b-actin, respectively, in PCRs on pericytes. We usually performed a negative control using RT-PCR instead of cDNA to check genomic DNA contamination. Furthermore, DNA sequencing of PCR products confirmed the specificity of our amplifications. Sequences were determined by the Centro Ricerca Interdipartimentale Biotecnologie Innovative (CRIBI)sequencing service at the University of Padova (Italy).
The PCR products were separated on 1.5% agarose gels in 13 Tris-acetate-EDTA buffer and stained with ethidium bromide. The bands on the ultraviolet light-transilluminated gel were converted into images, and their amounts were quantified with Scion Images software (Scion Corp., Frederick, MD).
Statistical analysis
Data are given as means 6 SEM. One-way ANOVA was performed to test for differences between groups. The StudentNewman-Keuls test was performed. P , 0.05 was considered to indicate statistical significance.
RESULTS
AA release
In ECs in noncontact cocultures with pericytes for 24 h, a statistically significant increase in AA release versus controls (ECs grown alone, no additions) was observed (Fig. 1A, B) .
Treatment of ECs in cocultures with wortmannin plus LY294002 (PI3-kinase inhibitors), PD98059 (MEK1 inhibitor), AACOCF 3 , or BEL induced a quite similar and sharp decrease in AA liberation compared with untreated cocultures (Fig. 1A, B) . Treatment with PI3-kinase or MEK1 inhibitors significantly (P , 0.01) suppressed pericyteinduced AA release, suggesting that PI3-protein kinase may be involved in free AA production. No significant dif- C]AA in F10 Ham's (ECs) or DMEM (pericytes) medium containing 2 mM glutamine and 5% fetal calf serum for 24 h and washed three times with HBSS medium containing 0.5% BSA before incubation with pericytes (B) or ECs (D) in noncontact cocultures alone or in combination with PI3-kinase, MEK1, or PLA 2 inhibitor. Cells were challenged with wortmannin (Wtm; 60 nM) plus LY294002 (20 mM), PD98059 (25 mM), arachidonoyl trifluoromethyl ketone (AACOCF 3 ; 50 mM), bromoenol lactone (BEL; 25 mM), or 5 mM EDTA for 24 h in serum-free DMEM (50%)-F10 Ham's (50%) medium. Endothelial or pericyte control cultures were also incubated in the presence of vehicle (DMSO) alone (i.e., no coculture conditions and without inhibitors). AA release into the culture medium was determined after extraction with ethyl acetate, as described in Experimental Procedures. Values represent means 6 SEM from three separate experiments. Statistically significant differences (* P , 0.05, ** P , 0.01) are indicated by asterisks. ferences were observed for endothelial control cultures (no additions) versus cell monocultures treated with wortmannin plus LY294002. No significant differences in AA release were observed for either pericyte control cultures (no additions) versus inhibitor-treated cell monocultures (Fig. 1C, D 3 , BEL, and EDTA resulted in, respectively, 71% (statistically significant at P , 0.01), 45% (statistically significant at P , 0.05), and 62% (statistically significant at P , 0.01) or 75% (statistically significant at P , 0.01), 44% (statistically significant at P , 0.05), and 56% (statistically significant at P , 0.01) decrease in AA release (Fig. 1A, C) . All of these findings reflect the inhibition of basal PLA 2 activity, which is the sum of cPLA 2 and iPLA 2 activities. As shown in Fig. 1B, AACOCF 3 , BEL, and EDTA were able to significantly inhibit stimulated AA release measured in the lysates of ECs in coculture. AACOCF 3 , an inhibitor of both cPLA 2 and iPLA 2 (29) , at 50 mM suppressed the pericyteenhanced AA release by 77%, whereas 25 mM BEL was able to decrease the pericyte-enhanced AA release by 57%. In addition, EDTA suppressed the pericyte-enhanced AA release by 83%. These results demonstrate that pericytestimulated AA release (an indirect index of total PLA 2 activity) in ECs was mediated by both PLA 2 enzymes, even though cPLA 2 activation may be the predominant fraction.
PLA 2 expression and the effect of kinase inhibitors
The participation of calcium-dependent PLA 2 , in addition to calcium-independent PLA 2 , in cell-induced AA liberation remained to be elucidated in all coculture models investigated to date. To clarify the role of both phospholipases upon cell stimulation in ECs and pericytes, we evaluated PLA 2 protein expression by Western blot analyses. Our results demonstrated that, in a coculture system that prevented physical contact but allowed the diffusion of soluble factors for 24 h, ECs significantly expressed cPLA 2 and iPLA 2 protein greater than ECs in solo cultures, respectively, by 55% (statistically significant at P , 0.05) and 85% (statistically significant at P , 0.01) (Fig. 2) . Equal loading in each lane was demonstrated by similar intensities of actin. These results demonstrated that in ECs, pericyte-stimulated total PLA 2 activity (Fig. 1A) might be mediated by both PLA 2 enzymes. In contrast, pericytes in the same coculture system showed no significant increase in either cPLA 2 or iPLA 2 protein expression. As shown in Fig. 2 , the presence of pericytes in the coculture induced an increase in the endothelial phosphorylated forms of p42/p44 MAPK (ERK1/2). No changes in total ERK1/2 protein expression were observed. Blots using anti-phospho-p42/p44 MAPK antibodies for pericytes did not show any change. These data indicate that in ECs, the ERK kinase phosphorylation and PLA 2 activation (Fig. 1) are coincident.
In addition, as shown in Fig. 3 , ECs coincubated for 24 h with pericytes in Transwell chambers (in this method of coculture, again, the pericytes are not in direct contact with ECs but are separated from them by the medium and a semipermeable membrane that can be crossed by soluble mediators) showed increases in the phosphorylated forms of cPLA 2 , PKCa, and ERK1/2 by 95, 128, and 300%, Fig. 2 . Western blot analyses of cytosolic phospholipase A 2 (cPLA 2 ), calcium-independent intracellular phospholipase A 2 (iPLA 2 ), total extracellular signal-regulated kinase (ERK) 1/2, and phosphorylated forms of ERK1/2 protein expression in bovine retinal pericyte and GP8.39 EC cocultures without direct contact. ECs were incubated in DMEM (50%)-F10 Ham's (50%) medium containing 10% FBS in Transwell chamber inserts (0.4 mm), and pericytes were seeded in the chamber beneath at the bottom of the plastic wells and vice versa. Harvested cells were lysed at 24 h after coincubation, and individual cell lysates were resolved by SDS-PAGE. Expressed proteins were independently revealed with cPLA 2 monoclonal antibody, iPLA 2 polyclonal antibody, ERK1/2 polyclonal antibody, anti-phospho-ERK monoclonal antibody, or actin monoclonal antibody as described in Experimental Procedures. Immunoreactive bands were visualized by chemiluminescence (ECL system; Amersham). All blots were controlled for equal loading by actin monoclonal antibody and were scanned to calculate the fold increase in antigen level. The values, expressed as arbitrary densitometric units (a.d.u.), were obtained by the reading of blots and are means 6 SEM of at least three independent experiments, each performed in triplicate; bar graphs represent net intensity of protein bands using the Scion Image program. Representative gel analyses are shown. ** P , 0.01, comparing cells in coculture with control cells grown alone, by pairwise Student's t-test.
respectively, compared with control cells grown alone. Equal loading in each lane was demonstrated by similar intensities of actin. In GP8.39 ECs, the constitutive phosphorylated form of cPLA 2 is seen at the ?40% level, whereas constitutive p-ERK1/2 were at 50%, as shown previously (29) . Thus, the increase of cPLA 2 synthesis and phosphorylation (p-cPLA 2 /cPLA 2 ratio from 0.37 to 0.93) may support an increase in cPLA 2 activity (Fig. 1) .
To investigate the possible signaling mechanisms by which pericytes may mediate the phosphorylation of endothelial cPLA 2 , we used inhibitors of PI3-kinase phosphorylation upstream of phosphorylating activities of endothelial PKCa and ERK1/2. Wortmannin (60 nM) plus LY294002 (20 mM), both inhibitors of upstream PI3-kinase, which regulates PKC phosphorylation, were able to significantly inhibit (p-cPLA 2 /cPLA 2 ratio from 0.93 to 0.28) the stimulated expression of phosphorylated cPLA 2 measured in the lysates of cocultured ECs for 24 h in the presence of both drugs (Fig. 3) . Preincubation of ECs and pericytes with wortmannin or LY294002 or a mixture of both inhibitors for 24 h did not result in significant changes in the viability of GP8.39 ECs ([3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl-tetrazolium bromide] test; mean of four independent experiments) compared with untreated controls (data not shown).
The inhibitor mixture also suppressed to almost the basal level the expression of the pericyte-enhanced phosphorylated form of endothelial PKCa (p-PKCa/PKCa ratio from 0.82 to 0.36), whereas the same inhibitors were able to decrease significantly pericyte-stimulated ERK1/2 phosphorylation by 3.3-fold. PKC is involved in the regulation of intracellular PLA 2 in several cell types. The strong effect of upstream phosphorylating activity inhibitors we observed in ECs may be attributable to the pivotal function of PKC isoforms in the control by basal phosphorylation of many target regulatory proteins all over the cell compartments, which also include PLA 2 , in both early (contraction and metabolism, for instance) and late (differentiation and proliferation) cellular events.
Therefore, these data indicate that immortalized ECs had good levels of endogenous cPLA 2 significantly increased by 24 h of exposure to medium conditioned by the copresence of pericytes. Treatment of ECs with kinase inhibitors reduced the cell content of cPLA 2 phosphorylated protein to the control level, providing evidence that soluble pericyte factors induced cPLA 2 protein increase by PKCa and MAPK action. Interestingly, skin fibroblasts were used as control cells for cocultures with ECs. Factors released in cultures by them had no comparable effects to pericytes (data not shown).
Upregulation of cPLA 2 and iPLA 2 mRNA by pericytes
As the presence of pericytes in coculture increased cPLA 2 and iPLA 2 protein synthesis in ECs, we next assessed cPLA 2 and iPLA 2 mRNA levels by RT-PCR after pericyte stimulation for 24 h. As depicted in Fig. 4A , pericytes induced a significant increase of endothelial cPLA 2 mRNA (?2.1-fold; P , 0.01 compared with control levels). We extended our study to mRNA expression of Ca 21 -independent PLA 2 (type VI iPLA 2 ). Results shown in Fig. 4A indicate that, in ECs grown in serum-containing medium in the presence of retinal pericytes, the type VI iPLA 2 gene was constitutively expressed and that pericyte-soluble factors caused an increase (?2.4-fold compared with basal levels) in iPLA 2 gene expression. In contrast, parallel evaluations for cPLA 2 and iPLA 2 mRNA in cocultured pericytes (Fig. 4B) did not show any significant change compared with cell monolayers. Fig. 3 . Western blot analyses of the effects of the protein kinase (PI3-kinase) inhibitors wortmannin and LY294002 on the expression of total protein and phosphorylated forms of cPLA 2 , protein kinase C (PKCa), and ERK1/2 in GP8.39 ECs cocultured with bovine retinal pericytes in a noncontact system. ECs and pericytes were incubated in DMEM (50%)-F10 Ham's (50%) medium containing 10% FBS for 24 h in the absence or presence of wortmannin (60 nM) plus LY294002 (20 mM). Harvested ECs were lysed at 24 h after treatment in coculture, lysates were resolved by SDS-PAGE, and expressed proteins were revealed with monoclonal antibody against cPLA 2 , monoclonal antibody against PKCa, polyclonal antibody against ERK1/2, monoclonal anti-phospho-cPLA 2 , polyclonal anti-phospho-PKCa, or monoclonal anti-phospho-ERK1/ 2 antibodies. All blots were controlled for equal loading by actin monoclonal antibody. The ratios of band intensity, phospho-cPLA 2 / total cPLA 2 or phospho-PKCa/total PKCa are indicated. The blots were probed with the ECL Western blot detection system and exposed to film (Kodak) for the same period of time. Bar graphs represent net intensity of protein bands using the Scion Image program. Values represent means 6 SEM from three independent experiments. Representative gel analyses are shown. * P , 0.05, ** P , 0.01, comparing cocultured ECs with control cells grown alone, by pairwise Student's t-test. a.d.u., arbitrary densitometric units.
Expression of PKCa in different coculture systems
Because endothelial PKCa is involved in stimulated p42/p44 MAPK phosphorylation by pericytes via the Raf-MEK pathway, indirectly suggesting that PLA 2 activation in ECs is mediated by PKCa, we analyzed the effect on PKCa expression of contact and noncontact conditions between cells in coculture. As shown in Fig. 5 , in either the noncontact model (Fig. 5A ) or the contact model (Fig. 5B) [i.e., ECs in contact with pericytes grown on the opposite sides of Transwell chamber inserts (pericyte processes made contact with opposing cell types through the semipermeable membrane)], the stimulation of endothelial PKCa protein expression reached almost the same values (2.0-to 2.5-fold). Equal loading in each lane was demonstrated by similar intensities of actin. On the contrary, pericyte PKCa did not show any stimulation (no statistical difference at P , 0.05); that is, the presence of ECs was without significant effect on pericyte protein expression.
Incidentally, in another set of experiments, mixed cultures of ECs and pericytes grown in contact on the same glass slide (Fig. 5C) showed the formation of net-like structures (phase-contrast micrograph).
Confocal microscopy
We next investigated by immunofluorescence microscopy the subcellular localization of PKCa in ECs and pericytes incubated in coculture for 24 h. To estimate PKCa fluorescence, ECs, double stained with a polyclonal vWF antibody coupled to a green fluorescent proteinlabeled secondary antibody (to highlight EC architecture) and with a monoclonal PKCa antibody coupled to red Cy3 antibody, were acquired separately with the FITC and Cy3 filters, and the intensity of fluorescence was determined and corrected for background measured in areas devoid of cells.
As illustrated in Fig. 6 , fusion of confocal images (Fig. 6A ) reveals PKCa faintly accumulating in the cytoplasm of control ECs grown alone, as shown by Cy3 in red ( Fig. 6C ; PKCa staining). After cocultivation for 24 h with pericytes, merged confocal images (Fig. 6A ¶) revealed considerable overlap of FITC with vWF and Cy3 with PKCa (yellow or orange) in the perinuclear area (white arrows) and widespread throughout the cell. Strong red fluorescence (Fig. 6C ¶; PKCa staining) suggests increased protein expression, and a major part of the pool of the PKCa isoform seems to be translocated into the perinuclear region and nucleus of ECs. vWF secretory granules are diffuse all over the cell body, and stimulation with pericytes in cocultures results in distinct clustering of a subset of Weibel-Palade bodies (WPBs) in the perinuclear region of the cell (Fig. 6B, B ¶) . Emission intensities of FITC (Fig. 6B, B ¶) and Cy3 (Fig. 6C , C ¶) were also evaluated with Leica confocal software, and pixel values inside the cells on a scale of 0-200 pixels (fluorescence arbitrary units) are reported in the graph for quantitative analysis. cPLA 2 expression in ECs before and after cocultures is shown in Fig. 7 . Cells were double stained with a polyclonal vWF antibody coupled to a green fluorescent protein-labeled secondary antibody (to highlight EC architecture) and with a monoclonal cPLA 2 antibody coupled to red Cy3 antibody. Intensity of fluorescence was determined separately with the FITC (Fig. 7B, B ¶) and Cy3 (Fig. 7C, C ¶) filters, and the merged images are shown (Fig. 7A, A ¶) . The merged image (Fig. 7A ¶) shows that the immunofluorescent signal of total cPLA 2 (yellow by overlapping of green/FITC and red/Cy3) is significantly greater in EC cocultures with pericytes than in ECs grown alone. Quantitative analysis of cPLA 2 emission intensity (fluorescence arbitrary units) demonstrated enhanced expression of the enzyme in cocultured ECs.
A major expression of PKCa and cPLA 2 was not induced in pericytes in the presence of ECs compared with control pericytes in the absence of ECs. Quantitative analyses of PKCa and cPLA 2 emission intensity were very similar in controls and in pericytes in cocultures, demonstrating no activation of both pericyte enzymes by ECs (data not shown). In addition, results concerning mixed cultures of ECs and pericytes grown for 24 h on the same glass slide in the well (mixed model with cells in direct physical contact) to observe PKCa reciprocal modulation show an intense red signal for PKCa in ECs compared with a faint signal in large pericytes (data not shown). In a similar manner, confocal micrographs of ECs and pericytes in cocultures grown on the same glass showed that the immunofluorescent signal of total cPLA 2 was significantly greater in ECs than in pericytes (data not shown).
DISCUSSION
Mural cells such as smooth muscle cells and pericytes are important for stabilizing EC-to-cell contacts because they may influence vessel type-specific differences of the endothelial phenotype. Most research on the in vitro BBB has been performed with ECs with or without astrocytes (35) . In the blood-nerve barrier, where cells equivalent to astrocytes are not found, endoneural pericytes support the integrity of the blood-nerve barrier determined by peripheral nerve microvascular ECs (36) . In addition, pericytes induce microvascular endothelial maturation, which requires the downregulation of EC proliferation and the formation of adhering and tight junctions. All these processes could be mediated by AA derivatives that function as a phenotypic switch (exocrine and autocrine loop). This signaling may be achieved directly through physical contact (gap junctions, N-cadherin expression) or indirectly through an exchange of soluble mediators (4, 37, 38) .
Although the in vitro growth conditions of ECs may be different from those seen in vivo, studies of their proliferation and cell interactions in vitro can be faithfully reproduced. This allows us to begin to determine the cross-talk between ECs and pericytes, which may play a role in neovascularization in vivo. To examine the role that pericytes might play in the formation of the BBB, we used immortalized rat brain EC-bovine retinal pericyte cocultures to mimic the phenotype cell-to-cell interactions that occur in microvessels in vivo. In this study, we tested the hypothesis that activation of the PKCa-ERK1/2-cPLA 2 pathway is involved particularly in several endothelial functions, including angiogenesis and BBB promotion.
Using the coculture system, we demonstrated that AA release, cPLA 2 , and iPLA 2 protein expression were enhanced in ECs when they were cocultured with pericytes compared with those measured in EC or pericyte monolayers alone (transcriptional reprogramming of ECs when exposed to pericytes). The switch for endothelial cPLA 2 as well as iPLA 2 protein synthesis and activity, induced by neighboring pericytes that share the same culture medium and that are separated by a microporous insert ( juxtacrine signaling previously unknown), might serve to produce endothelium-derived prostaglandins (PGE 2 and PGF 2 a) and prostacyclin. Our preliminary results indicated that cyclooxygenase-2, but not 15-lipoxygenase, was highly expressed in ECs cultured directly with pericytes for 24 h. Prostanoids may act as endogenous stimulators of angiogenesis (39) , vascular cell adhesion molecule-1 expression, EC migration via autocrine and paracrine loop (40) , and finally as a protection against early atherothrombogenesis.
It is known from previous studies that pericytes (or conditioned medium of retinal pericytes) inhibit EC migration and proliferation in cell culture (8) (9) (10) . This inhibitory or antiangiogenic activity is mediated by pericyte TGF-b, which becomes activated mainly when pericytes make contact with ECs. ECs in turn release platelet-derived growth factor-b, which induces pericytes to migrate toward the endothelium and to make contact (3, 41) . Thus, cells of the vessel wall and ECs reciprocally activate mechanisms, mediated by extracellular factors, that induce coordinated vascular differentiation.
Investigating signaling pathways triggered intracellularly, we report here that the pericyte presence induces a sustained phosphorylation of cPLA 2 and ERK1/2, with a concomitant increase in PKCa protein expression, regardless of the type of cell-to-cell interactions (i.e., either in the noncontact or the contact coculture model).
Our results suggest that proteins that play a role in signaling are upregulated particularly in ECs after 24 h in coculture with pericytes. These observations are consistent with previous published data demonstrating transient activation of PKC and increased phosphorylation of 85 kDa myristoylated adenine-rich C-kinase substrate protein induced by astrocytes in proliferating cerebromicrovascular ECs (42) .
In our study, signaling pathways were explored using pharmacological inhibitors of PI3-kinase (wortmannin plus LY294002) and MEK1 (PD98059). Wortmannin plus LY294002 blocked the pericyte-induced enhanced expression of phosphorylated forms of cPLA 2 , PKCa, and ERK1/ 2, whereas both inhibitors had similar effects in blocking stimulated AA release in EC cocultures. These findings suggest that activation of PKCa, ERK1/2, and PLA 2 enzymes may involve a mechanism dependent on PI3-PDK1 kinases. Extensive studies have provided evidence that 3 ¶-phosphoinositide-dependent protein kinase and PDK1 phosphorylate and activate members of the ABC protein kinase family and play an important role in the regulation of cell survival, differentiation, and proliferation (43) .
More than 12 PKC isozymes, the conventional PKCs (a, b, g), novel PKCs (y, y, h), and atypical PKCs (z), have been found over the years. Previously, it was demonstrated that PKC isoforms (a, b, g, y, y, z) were detected in vascular ECs (44) (45) (46) (47) (48) . The expression pattern of PKC isozymes, including a, b, y, y, and the calcium-and diacylglycerol-independent z isoform, was also demonstrated to be present in pericytes (44, 45, 49) . Ca 21 -dependent PKCa isoform is required for ERK signaling to trigger gene expression of cPLA 2 .
Previously, we have demonstrated that PKC activation is required for ERK-cPLA 2 phosphorylation after stimulation of ECs by oxidized LDL (29) . Here, we have investigated how the interaction between the MAPK cascade and PKC affects ERK1/2 activation and phosphorylation upon cellto-cell interaction in coculture. Our results suggest that activation of cPLA 2 through the activation of PKCa is the main mechanism by which the cross-talk between pericytes and ECs develops. In fact, total PKC expression and PKCa translocation from the cytosol to the membrane system and the nucleus was increased in cocultures compared with both cell cultures grown alone. It has been established that PKCa is a predominantly cytosolic protein but is able to translocate to the membrane fraction after stimulation. The exact subcellular location, plasma membrane or nucleus, of PKC after stimulation varies depending on the cell line and the stimulus (17, 50, 51) . vWF is an adhesive glycoprotein involved in primary hemostasis and synthesized in ECs, where it is stored in WPBs. vWF secretory granules are diffuse all over the cytoplasm, and intracellular vWF trafficking encompasses exocytosis on EC stimulation after vascular injury. In addition, stimulation with cAMP-increasing agonists (forskolin and epinephrine) results in distinct clustering of a subset of WPBs (escaping rapid secretion) in the perinuclear region of the cell (52) . cAMP-dependent perinuclear recruitment of WPBs might provide a means to limit the excessive release of prothrombotic and proinflammatory mediators stored in WPBs under physiological conditions. Furthermore, cAMP-increasing agents improve barrier function in EC monolayers accompanied by a tightening of cell-to-cell contacts (53) , probably by stimulating the phosphorylation of protein involved in the junctions or in cytoskeleton (54) . It has also been shown that dibutyryl cAMP induced a phenotypically differentiated cell as well as the establishment of endothelial permeability barriers (tightening of EC cell-to-cell contacts) and increased the recruitment and cytoskeleton association of the tight junctional proteins (occludin, ZO-1, ZO-2) (55). Cocultures of ECs with smooth muscle-like 10T1/2 mimic the same effect. Therefore, the likeliest explanation for the nuclear localization of vWF observed in our confocal micrograph preparations of confluent ECs (Fig. 7) is that pericytesoluble factors, favoring cell retraction, stress fiber disruption and cytoskeletal remodeling and antagonize the central granular movement from the Golgi area to the cell plasma membrane.
In agreement with our previous results in ECs (33) , the intense staining of cPLA 2 seems to be associated with the nuclear compartment (Fig. 7) . Translocation of cPLA 2 a from the cytosol to the perinuclear membrane, where downstream eicosanoid-synthetic enzymes such as cyclooxygenase and 5-lipoxygenase are localized, has been reported by several groups (24, 25, 33) . Indeed, targeting of cPLA 2 to the Golgi and endoplasmic reticulum membranes in CHO and MDCK cells activated by intracellular Ca 21 concentration increase has been demonstrated (26) . More recently, in human ECs after stimulation with the calcium-mobilizing agonist A23187, relocation of cPLA 2 a occurred to the endoplasmic reticulum, the Golgi, and primarily to both the inner and outer surfaces of the nuclear membrane (27) . This process appears to be cell-specific and dependent on the proliferation state of ECs. Tashiro et al. (56) recently confirmed the presence of nuclear localization and export signals within the cPLA 2 a protein.
In summary, our results demonstrate that the presence of pericytes activates the endothelial PKCa/ERK1/2 pathway, an essential step for augmented cPLA 2 expression in ECs regardless of coculture conditions. AA-derived prostanoids in endothelium might act as endogenous stabilizers of cellto-cell contacts and stimulators of angiogenesis.
